Trial Profile
A phase I trial of ALG 1001 in patients with advanced stage diabetic macular oedema.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2013
Price :
$35
*
At a glance
- Drugs Risuteganib (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2011 New trial record